Telaprevir Tops Japanese Hospital Drug Use List
This article was originally published in PharmAsia News
Executive Summary
Despite a postmarketing all-case surveillance condition, hepatitis C treatment Incivek (telaprevir) was ranked No. 1 in Japan’s hospital market.